Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Aurigene Signs Long-Term Manufacturing Deal With Global Pharma Company | Contract Pharma

What are you searching for?

Sign in
Breaking News, Collaborations & Alliances

Aurigene Signs Long-Term Manufacturing Deal With Global Pharma Company

The agreement covers commercial manufacturing and supply of 20+ sterile injectables, biologics and topical products across key global markets.

Author Image

By: Charlie Sternberg

Associate Editor, Contract Pharma

Aurigene Pharmaceutical Services Limited, a wholly owned subsidiary of Dr. Reddy’s Laboratories Ltd., has entered a strategic, long-term Manufacturing and Supply Agreement with a global pharmaceutical company for the commercial drug-product manufacturing and supply of a diversified portfolio for USA, Europe, Canada and Emerging markets.

The agreement establishes a full-service framework for technical transfer, process development, scale-up, validation, commercial manufacturing and long-term supply, and highlights Aurigene’s expanding drug product CDMO and CMO capabilities.

The initial portfolio comprises 20+ products spanning sterile injectables, biologics and topicals, to be manufactured across facilities in India. The partnership is expected to progress through a phased technology transfer program over the next two to three years, paving the way for commercial manufacturing and supply. At full commercialization, the portfolio is expected to represent an estimated annual volume of approximately 18 million units—largely injectables.

“We are delighted to enter into this strategic, long-term collaboration,” said Akhil Ravi, CEO, Aurigene Pharmaceutical Services. “This partnership reflects the confidence global innovators place in our integrated drug-product development and manufacturing capabilities of sterile injectables, biologics and topicals, our proven quality and regulatory track record, and our ability to support complex technology transfers and commercial supply. It provides long-term revenue visibility, accelerates the scale-up of our drug-product business, and reinforces our commitment to reliable, high-quality supply to patients worldwide.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics